Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2)


Cite item

Full Text

Abstract

The paper gives current approaches to treating chronic thromboembolic pulmonary hypertension (CTEPH) from the document «Federal Guidelines for the Diagnosis and Treatment of CTEPH» approved at the Third Russian Congress on Pulmonary Hypertension on December 11, 2015. The guidelines had been elaborated to optimize the treatment of patients with CTEPH on the basis of an analysis of the data of the present-day registries and multicenter randomized clinical trials, national and international guidelines and consensus documents, and documents published in recent years. CTEPH is a unique form of pulmonary hypertension since it is potentially curable by surgical treatment. The paper presents indications for and contraindications to pulmonary thromboendartectomy; preparation for surgery; operating room facilities; the specific features of postoperative management and possible complications; and long-term results. In terms of therapy, in addition to non-pharmacological measures, the authors discuss maintenance and specific treatment options for CTEPH, balloon pulmonary angioplasty, and lung/heart-lung transplantation. In conclusion, they propose a management algorithm in patients with CTEPH and requirements for its problem to the center of experts.

About the authors

I E Chazova

T V Martynyuk

References

  1. Чазова И.Е., Авдеев С.Н., Царева Н.А., Волков А.В., Мартынюк Т.В., Наконечников С.Н. Клинические рекомендации по диагностике и лечению легочной гипертонии. Терапевтическийархив. 2014;9:4-23.
  2. Mereles D, Ehlken N, Kreuscher S et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006;114:1482-1489. doi: 10.1161/CIRCULATIONAHA.106.618397
  3. The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J. 2003;24:761-781. doi: 10.1016/S0195-668X(03)00098-8
  4. Galie N, Humbert M, Vachiery JL et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J. 2015;46(4):903-975. doi: 10.1183/13993003.01032-2015
  5. Мершин К.В., Акчурин Р.С. Хроническая тромбоэмболическая легочная гипертензия. В кн.: Легочная гипертензия. Под ред. Чазовой И.Е., Мартынюк Т.В. М.: Практика; 2015.
  6. Чернявский А.М. Хроническая постэмболическая легочная гипертензия. В кн.: Легочная гипертензия. Под ред. Авдеева С.Н. М.; ГЭОТАР-Медиа; 2015.
  7. Keith McNeil, John Dunning. Chronic thromboembolic pulmonary hypertension (CTEPH) Heart. 2007;93(9):1152-1158. doi: 10.1136/hrt.2004.053603
  8. Berman M, Tsui S, Vuylsteke A et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thorac Surg. 2008;86:1261-1267. doi: 10.1016/j.athoracsur.2008.06.037
  9. Mayer E, Jenkins D, Lindner J et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141:702-710. doi: 10.1016/j.jtcvs.2010.11.024
  10. Kim NH, Delcroix M, Jenkins DP et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62:D92-D99. doi: 10.1016/j.jacc.2013.10.024
  11. Thistlethwaite PA, Madani MM, Kemp AD et al. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. AnnThorac Surg. 2006;82:2139-2145. doi: 10.1016/j.athoracsur.2006.07.020
  12. Wilkens H, Lang I, Behr J et al. Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension. Chronic thromboembolic pulmonary hypertension (CTEPH): updated Recommendations of the Cologne Consensus Conference 2011.Respirhttp://www.ncbi.nlm.nih.gov/pubmed/23978639Invesцtig. 2013;51(3):134-146. doi: 10.1016/S0167-5273(11)70493-4
  13. Mehta S, Helmersen D, Provencher S et al. Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline. Can Respir J.2010;17(6):301-334. doi: 10.1155/2010/704258
  14. Pepke-Zaba J, Hoeper MM, Humbert M. Chronic thromboembolic pulmonary hypertension: advances from bench to patient management. Eur Respir J. 2013;41:8-9. doi: 10.1183/09031936.00181212
  15. Мершин К.В., Мартынюк Т.В. Место медикаментозной терапии в лечении хронической тромбоэмболической легочной гипертензии. Евразийский кардиологический журнал. 2014;1:113-118.
  16. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation. 2006;113:2011-2020. doi: 10.1161/CIRCULATIONAHA.105.602565
  17. Ghofrani HA, Hoeper MM, Halank M et al. Riociguat for chronic Thromboembolic pulmonary hypertension and pulmonary arterial hypertension: A phase II study. Eur Respir J. 2010;36:792-799. doi: 10.1183/09031936.00182909
  18. Ghofrani HA, D’Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369:319-329. doi: 10.1056/NEJMoa1209657
  19. Skoro-Sajer N, Bonderman D, Wiesbauer F et al. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2007;5:483-489. doi: 10.1111/j.1538-7836.2007.02394.x
  20. Olschewski H, Simonneau G, Galiè N et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med.2002;347(5):322-329. doi: 10.1056/NEJMoa020204
  21. Jaı¨s X, D’Armini AM, Jansa P, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008;52:2127-2134. doi: 10.1016/j.jacc.2008.08.059
  22. Galiè N, Ghofrani HA, Torbicki A et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med.2005;353(20):2148-2157. doi: 10.1056/NEJMoa050010
  23. Reichenberger F, Voswinckel R, Enke B et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2007;30:922-927. doi: 10.1183/09031936.00039007
  24. Kataoka M, Inami T, Hayashida K et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5:756-762. doi: 10.1161/CIRCINTERVENTIONS.112.971390
  25. Sugimura K, Fukumoto Y, Satoh K et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76:485-488. doi: 10.1253/circj.CJ-11-1217
  26. Данилов Н.М., Матчин Ю.Г., Мартынюк Т.В. и др. Транслюминальная баллонная ангиопластика легочных артерий у больных с неоперабельной хронической тромбоэмболической легочной гипертензией (первый опыт в России). Consilium medicum. 2015;10:61-66.
  27. Inami T, Kataoka M, Shimura N et al. Pulmonary edema predictive scoring index (PEPSI), a new indexto predict risk of reperfusion pulmonary edema and improvement of hemodynamicsin percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv. 2013;6:725-736. doi: 10.1016/j.jcin.2013.03.009

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies